Not available
Quote | Chembio Diagnostics Inc. (NASDAQ:CEMI)
Last: | $0.455 |
---|---|
Change Percent: | 1.65% |
Open: | $0.4475 |
Close: | $0.455 |
High: | $0.455 |
Low: | $0.447 |
Volume: | 351,642 |
Last Trade Date Time: | 04/27/2023 03:00:00 am |
News | Chembio Diagnostics Inc. (NASDAQ:CEMI)
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
Message Board Posts | Chembio Diagnostics Inc. (NASDAQ:CEMI)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CEMI News Article - Biosynex Extends Tender Offer for the shares of Chembio Diagnostic | whytestocks | investorshangout | 03/15/2023 12:00:46 PM |
Chembio Diagnostics: SEC Admin. Proceeding; | Renee | investorshub | 03/03/2023 2:38:02 PM |
Does the company that is buying chembio trade | 2248 | investorshub | 02/02/2023 8:55:29 PM |
whytestocks: $CEMI News Article - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATCX, CEM | whytestocks | investorshangout | 02/01/2023 3:15:46 PM |
whytestocks: $CEMI News Article - CEMI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sa | whytestocks | investorshangout | 02/01/2023 3:10:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...